Gliclazide Mr Brillpharma (Ireland)

Gliclazide MR Brillpharma (Ireland) is a modified-release oral medication used to manage type 2 diabetes. It helps control blood sugar levels by stimulating insulin production. This medication is manufactured by Brillpharma (Ireland) Limited.

Gliclazide MR is primarily used to treat type 2 diabetes mellitus. It works by helping the pancreas produce more insulin, which helps lower blood sugar levels. This medication is often prescribed as part of a broader diabetes management plan, which may include diet and exercise. People often ask, 'What is Gliclazide MR used for?' and the answer is that it is used to help manage blood sugar levels in adults with type 2 diabetes.

Common effects of Gliclazide MR may include hypoglycemia, or low blood sugar, especially if meals are skipped or delayed. Other potential effects include nausea, dizziness, and weight gain. It is important to monitor blood sugar levels regularly while taking this medication.

Gliclazide MR should be taken as directed by a healthcare professional. It is important to follow a consistent diet and exercise routine to avoid fluctuations in blood sugar levels. This medication should be stored at room temperature and kept out of reach of children. Always inform your healthcare provider about any other medications you are taking.

Gliclazide MR may interact with other medications, including certain antibiotics, antifungal drugs, and other diabetes medications. Alcohol can also affect blood sugar levels and should be consumed with caution. Always consult a healthcare professional before starting or stopping any medication.